Based on our previously reported genetic data indicating that genetic disruption of Acs1 increases fluconazole efficacy and synergy of isoxazole 1 with fluconazole (23), we further investigated the in vitro toxicity and in vitro pharmacodynamic properties of 1 as a prelude to potential efficacy studies in a mouse model of infection. This evidence concerns the gene ACSL1 and infection.